Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhammad Ishrat Husain

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
BMJ Open|February 26, 2025
Narrative enhancement and cognitive therapy for self-stigma among youth with bipolar disorder or multiple mental health conditions: protocol for a pilot randomised basket trialLisa D Hawke, Muhammad Ishrat Husain, Abigail Amartey, et al.
BMC Psychiatry|April 17, 2020
Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2)Muhammad Ishrat Husain, Clare Cullen, Madeha Umer, et al.
International Review of Psychiatry (Abingdon, England)|June 6, 2020
Relative effectiveness of augmentation treatments for treatment-resistant depression: a systematic review and network meta-analysisBen Carter, Rebecca Strawbridge, Muhammad Ishrat Husain, et al.
Plos One|December 23, 2025
Adaptation and evaluation of a digital dialectical behaviour therapy for youth at clinical high risk for psychosis: A protocol for a feasibility randomized controlled trialThea Lynne Hedemann, Yun Lu, Sofia Campitelli, et al.
The Lancet. Psychiatry|May 24, 2020
Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trialMuhammad Ishrat Husain, Imran B Chaudhry, Ameer B Khoso, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|February 18, 2026
Magnitude of Response in Treatment and Control Groups within Psychedelic Trials for Psychiatric Disorders: A Meta-AnalysisShakila Meshkat, Qiaowei Lin, Rachel Sousa-Ho, et al.
Bjpsych Open|May 9, 2025
The effect of the quality of the national health security systems in 12 countries on the prevalence of suicide crisis syndrome during the COVID-19 pandemicFerdinand Bortenschlager, Maximilian Lutz, Judith Streb, et al.
Ebiomedicine|July 10, 2026
Loss of vesicular monoamine transporter 2 in striatum of long COVID and relationship to neuropsychiatric symptomsYuhan Karida Liu, Devina Persaud, Erica L Vieira, et al.
The Australian and New Zealand Journal of Psychiatry|October 23, 2020
Minocycline as adjunctive treatment for major depressive disorder: Pooled data from two randomized controlled trialsRobson Zazula, Muhammad Ishrat Husain, Mohammadreza Mohebbi, et al.
BMJ Open|September 26, 2025
Understanding Canadian experiences of suicidality during the COVID-19 pandemic: protocol of a pan-Canadian qualitative studyParia Baharikhoob, Elisa Hollenberg, Ari B Cuperfain, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
BMJ Open|February 26, 2025
Narrative enhancement and cognitive therapy for self-stigma among youth with bipolar disorder or multiple mental health conditions: protocol for a pilot randomised basket trialLisa D Hawke, Muhammad Ishrat Husain, Abigail Amartey, et al.
BMC Psychiatry|April 17, 2020
Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2)Muhammad Ishrat Husain, Clare Cullen, Madeha Umer, et al.
International Review of Psychiatry (Abingdon, England)|June 6, 2020
Relative effectiveness of augmentation treatments for treatment-resistant depression: a systematic review and network meta-analysisBen Carter, Rebecca Strawbridge, Muhammad Ishrat Husain, et al.
Plos One|December 23, 2025
Adaptation and evaluation of a digital dialectical behaviour therapy for youth at clinical high risk for psychosis: A protocol for a feasibility randomized controlled trialThea Lynne Hedemann, Yun Lu, Sofia Campitelli, et al.
The Lancet. Psychiatry|May 24, 2020
Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trialMuhammad Ishrat Husain, Imran B Chaudhry, Ameer B Khoso, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|February 18, 2026
Magnitude of Response in Treatment and Control Groups within Psychedelic Trials for Psychiatric Disorders: A Meta-AnalysisShakila Meshkat, Qiaowei Lin, Rachel Sousa-Ho, et al.
Bjpsych Open|May 9, 2025
The effect of the quality of the national health security systems in 12 countries on the prevalence of suicide crisis syndrome during the COVID-19 pandemicFerdinand Bortenschlager, Maximilian Lutz, Judith Streb, et al.
Ebiomedicine|July 10, 2026
Loss of vesicular monoamine transporter 2 in striatum of long COVID and relationship to neuropsychiatric symptomsYuhan Karida Liu, Devina Persaud, Erica L Vieira, et al.
The Australian and New Zealand Journal of Psychiatry|October 23, 2020
Minocycline as adjunctive treatment for major depressive disorder: Pooled data from two randomized controlled trialsRobson Zazula, Muhammad Ishrat Husain, Mohammadreza Mohebbi, et al.
BMJ Open|September 26, 2025
Understanding Canadian experiences of suicidality during the COVID-19 pandemic: protocol of a pan-Canadian qualitative studyParia Baharikhoob, Elisa Hollenberg, Ari B Cuperfain, et al.
Pageof 7